Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
203.21
+13.20 (6.95%)
At close: Oct 5, 2026, 4:00 PM EDT
202.69
-0.52 (-0.26%)
Pre-market: Oct 6, 2026, 7:51 AM EDT
Moderna Market Cap
Moderna has a market cap or net worth of $81.13 billion as of October 5, 2026. Its market cap has increased by 629.07% in one year.
Market Cap
81.13B
Enterprise Value
75.51B
1-Year Change
629.07%
Ranking
Category
Stock Price
$203.21
ChartMarket Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $81.13B, an increase of 1,225.97%. That is a compound annual growth rate of 39.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 81.13B | 604.08% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vertex Pharmaceuticals | 127.93B |
| Regeneron Pharmaceuticals | 73.41B |
| argenx SE | 57.39B |
| Revolution Medicines | 44.29B |
| BeOne Medicines AG | 40.71B |
| Royalty Pharma | 32.87B |
| Alnylam Pharmaceuticals | 29.40B |
| Roivant Sciences | 25.80B |